Inhaled corticosteroid therapy with nebulized beclometasone dipropionate

Pulmonary Pharmacology and Therapeutics

Volumn 23, Issue 3, 2010, Pages 145-155

  Nicolini, Gabriele ^a   Cremonesi, Giovanni ^a   Melani, Andrea S ^b  

^a CHIESI FARMACEUTICI S P A   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Beclometasone dipropionate; Chronic persistent asthma; Hand held inhalers; Inhaled corticosteroids; Jet nebulizers; Nebulization; Nebulizer therapy; Ultrasonic nebulizers

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; SALBUTAMOL;

ASTHMA; BODY HEIGHT; BONE METABOLISM; CHEST TIGHTNESS; CORTICOSTEROID THERAPY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; DRY EYE; HEADACHE; HOARSENESS; HUMAN; HYDROCORTISONE URINE LEVEL; INHALATION SPACER; INHALER; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; OROPHARYNX CANDIDIASIS; PRIORITY JOURNAL; REVIEW; SORE THROAT; TACHYCARDIA; TREMOR; XEROSTOMIA;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; CLINICAL TRIALS AS TOPIC; FORCED EXPIRATORY VOLUME; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PRACTICE GUIDELINES AS TOPIC;

EID: 77950341150     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.11.003     Document Type: Review

References (89)

1. Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J 15 6 (2006) 326-331
2. Dessanges J.F. A history of nebulization. J Aerosol Med 14 1 (2001) 65-71
3. Simon R.A. Update on inhaled corticosteroids: safety, compliance, and new delivery systems. Allergy Asthma Proc 20 3 (1999) 161-165
4. Suissa S., Ernst P., Benayoun S., Baltzan M., and Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343 5 (2000) 332-336
5. Barnes N.C. The properties of inhaled corticosteroids: similarities and differences. Prim Care Respir J 16 3 (2007) 149-154
6. Rau J.L. The inhalation of drugs: advantages and problems. Respir Care 50 3 (2005) 367-382
7. Anderson P.J. History of aerosol therapy: liquid nebulization to MDIs to DPIs. Respir Care 50 9 (2005) 1139-1150
8. Dolovich M.B. Measuring total and regional lung deposition using inhaled radiotracers. J Aerosol Med 14 Suppl. 1 (2001) S35-S44
9. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159 9 (1999) 941-955
10. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World health Organization, GA(2)LEN and AllerGen). Allergy 63 Suppl. 86 (2008) 8-160
11. Clinical practice guideline: management of sinusitis. Pediatrics 108 3 (2001) 798-808
12. Caronzolo D., Lucini V., Pannacci M., Grosso S., Colleoni F., Fraschini F., et al. Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae. Antimicrob Agents Chemother 48 12 (2004) 4878-4881
13. Nelsen N.A. Treatment of asthmatic attacks by inhalation of adrenaline. Lancet (1936) 846-849
14. Tiffeneau R. Le traitment de l'asthme par les aérosols bronchodilatateurs. Paris Med 7 (1943) 46-48
15. British Thoracic Society Nebulizer Project Group. Nebulizer therapy. Guidelines. Thorax 52 Suppl. 2 (1997) S4-S24
16. Boe J., Dennis J.H., O'Driscoll B.R., Bauer T.T., Carone M., Dautzenberg B., et al. European respiratory Society guidelines on the use of nebulizers. Eur Respir J 18 1 (2001) 228-242
17. Global Initiative for Asthma. Global strategy for asthma management and prevention. [cited 2008 March 27]. Available from (2008). www.ginasthma.com
18. Barry P.W., and O'Callaghan C. Nebuliser therapy in childhood. Thorax 52 Suppl. 2 (1997) S78-S88
19. Szefler S.J., Baker J.W., Uryniak T., Goldman M., and Silkoff P.E. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 120 5 (2007) 1043-1050
20. de Blic J., Delacourt C., Le Bourgeois M., Mahut B., Ostinelli J., Caswell C., et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 98 1 (1996) 14-20
21. Szefler S.J. Clinical need for a nebulized corticosteroid. J Allergy Clin Immunol 104 4 Pt 2 (1999) 162-168
22. Bisgaard H., and Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol 42 8 (2007) 723-728
23. Parkin P.C., Saunders N.R., Diamond S.A., Winders P.M., and Macarthur C. Randomised trial spacer v nebuliser for acute asthma. Arch Dis Child 72 3 (1995) 239-240
24. Ward M.J. Nebulisers for asthma. Thorax 52 Suppl. 2 (1997) S45-S48
25. Dolovich M.B., Ahrens R.C., Hess D.R., Anderson P., Dhand R., Rau J.L., et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of chest Physicians/American College of asthma, Allergy, and Immunology. Chest 127 1 (2005) 335-371
26. Everard M.L. Guidelines for devices and choices. J Aerosol Med 14 Suppl. 1 (2001) S59-S64
27. Brocklebank D., Ram F., Wright J., Barry P., Cates C., Davies L., et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 5 26 (2001)
28. Thomas M., and Williams A.E. Are outcomes the same with all dry powder inhalers?. Int J Clin Pract Suppl 149 (2005) 33-35
29. Brownlee K.G. A rationale for the use of nebulized steroids in children. Eur Respir Rev 7 44 (1997) 177-179
30. Boyter A.C., and Carter R. How do patients use their nebuliser in the community?. Respir Med 99 11 (2005) 1413-1417
31. McLaughlin T., Leibman C., Patel P., and Camargo Jr. C.A. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications. Curr Med Res Opin 23 6 (2007) 1319-1328
32. Barnes P.J. Achieving asthma control. Curr Med Res Opin 21 Suppl. 4 (2005) S5-S9
33. Crompton G.K. How to achieve good compliance with inhaled asthma therapy. Respir Med 98 Suppl. B (2004) S35-S40
34. Nicolini G., Scichilone N., Bizzi A., Papi A., and Fabbri L.M. Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations. Ther Clin Risk Manage 4 5 (2008) 855-864
35. Tarsin W.Y., Pearson S.B., Assi K.H., and Chrystyn H. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. Int J Pharm 316 1-2 (2006) 131-137
36. Janssens W., VandenBrande P., Hardeman E., De Langhe E., Philps T., Troosters T., et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J 31 1 (2008) 78-83
37. Jarvis S., Ind P.W., and Shiner R.J. Inhaled therapy in elderly COPD patients; time for re-evaluation?. Age Ageing 36 2 (2007) 213-218
38. Cates C.J., Crilly J.A., and Rowe B.H. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2 (2006) CD000052
39. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 63 Suppl. 4 (2008) iv1-iv121
40. Rau J.L., Ari A., and Restrepo R.D. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 49 2 (2004) 174-179
41. Terzano C., and Allegra L. Importance of drug delivery system in steroid aerosol therapy via nebulizer. Pulm Pharmacol Ther 15 5 (2002) 449-454
42. Pritchard J.N. The influence of lung deposition on clinical response. J Aerosol Med 14 Suppl. 1 (2001) S19-S26
43. Terzano C., Petroianni A., Parola D., and Ricci A. Compressor/nebulizers differences in the nebulization of corticosteroids. The CODE study (Corticosteroids and Devices Efficiency). Eur Rev Med Pharmacol Sci 11 4 (2007) 225-237
44. Köhler E., Jilg G., Avenarius S., and Jorch G. Lung deposition after inhalation with various nebulisers in preterm infants. Arch Dis Child Fetal Neonatal Ed 93 4 (2008) F275-F279
45. Nicolini G., and Panza I. Nebulization of inhaled corticosteroid viscous solutions by ultrasonic nebulizer. Allergy 57 Suppl. 73 (2002) 339
46. Di Berardino L., and Scaglione F. Mixing albuterol and corticosteroid is not additive. Allergy 54 9 (1999) 1012-1013
47. Berlinski A., and Waldrep J.C. Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med 19 4 (2006) 484-490
48. Amirav I., and Newhouse M.T. Aerosol therapy in infants and toddlers: past, present and future. Expert Rev Resp Med 2 5 (2008) 597-605
49. Becquemin M.H., Swift D.L., Bouchikhi A., Roy M., and Teillac A. Particle deposition and resistance in the noses of adults and children. Eur Respir J 4 6 (1991) 694-702
50. Cockcroft D.W., MacCormack D.W., Tarlo S.M., Hargreave F.E., and Pengelly L.D. Nasal airway inspiratory resistance. Am Rev Respir Dis 119 6 (1979) 921-926
51. Anhoj J., Thorsson L., and Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 162 5 (2000) 1819-1822
52. Everard M.L. Inhalation therapy for infants. Adv Drug Deliv Rev 55 7 (2003) 869-878
53. Smaldone G.C., Berg E., and Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 18 3 (2005) 354-363
54. Marguet C., Couderc L., Le Roux P., Jeannot E., Lefay V., and Mallet E. Inhalation treatment: errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. Pediatr Allergy Immunol 12 4 (2001) 224-230
55. Janssens H.M., van der Wiel E.C., Verbraak A.F., de Jongste J.C., Merkus P.J., and Tiddens H.A. Aerosol therapy and the fighting toddler: is administration during sleep an alternative?. J Aerosol Med 16 4 (2003) 395-400
56. Esposito-Festen J., Ijsselstijn H., Hop W., van Vliet F., de Jongste J., and Tiddens H. Aerosol therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do?. Chest 130 2 (2006) 487-492
57. Amirav I., Balanov I., Gorenberg M., Groshar D., and Luder A.S. Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!. Arch Dis Child 88 8 (2003) 719-723
58. WHO model list of essential medicines, 15th list. 2007 [cited 2009 19 February]; Available from (March 2007), World Health Organization, Geneva. http://www.who.int/medicines/publications/08_ENGLISH_indexFINAL_EML15.pdf
59. Abdullah A.K., and Khan S. Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma. J Asthma 44 1 (2007) 1-12
60. Bousquet J., and Delacourt C. Introduction. Nebulized beclometasone dipropionate therapy in asthma. Respir Med 97 Suppl. B (2003) S1-S4
61. Kelly H.W. Comparison of inhaled corticosteroids: an update. Ann Pharmacother 43 3 (2009) 519-527
62. Rohatagi S., Appajosyula S., Derendorf H., Szefler S., Nave R., Zech K., et al. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. J Clin Pharmacol 44 1 (2004) 37-47
63. Colice G.L. Pharmacodynamic and pharmacokinetic considerations in choosing an inhaled corticosteroid. Treat Respir Med 5 4 (2006) 245-253
64. Derendorf H., Nave R., Drollmann A., Cerasoli F., and Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J 28 5 (2006) 1042-1050
65. Daley-Yates P.T., Price A.C., Sisson J.R., Pereira A., and Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 51 5 (2001) 400-409
66. Baptist A.P., and Reddy R.C. Inhaled corticosteroids for asthma: are they all the same?. J Clin Pharm Ther 34 1 (2009) 1-12
67. Poli G., and Acerbi D. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers. Respir Med 97 Suppl. B (2003) S5-S9
68. La Grutta S., Nicolini G., Capristo C., Bellodi S.C., and Rossi G.A. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children. Monaldi Arch Chest Dis 67 1 (2007) 30-38
69. Pedersen W., and Prahl P. Jet-nebulized beclomethasone dipropionate in the management of bronchial asthma. Topical steroids for asthmatic children younger than 4 years. Allergy 42 4 (1987) 272-275
70. Storr J., Lenney C.A., and Lenney W. Nebulised beclomethasone dipropionate in preschool asthma. Arch Dis Child 61 3 (1986) 270-273
71. Carlsen K.H., Leegaard J., Larsen S., and Orstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 63 12 (1988) 1428-1433
72. Ghirga G., Ghirga P., Fagioli S., and Colaiacomo M. Intermittent treatment with high dose nebulized beclomethasone for recurrent wheezing in infants due to upper respiratory tract infection. Minerva Pediatr 54 3 (2002) 217-220
73. Papi A., Nicolini G., Baraldi E., Boner A.L., Cutrera R., Rossi G.A., et al. Regular vs prn nebulized treatment for wheeze in preschool children. Am J Respir Crit Care Med 179 (2009) A4818
74. Bisca N., Cernatescu I., Dragomir D., Iacomi A., Mirceau M., and Orascanu D. Comparison of the efficacy and safety of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in paediatric patients with moderate to severe exacerbation of asthma. Respir Med 97 Suppl. B (2003) S15-S20
75. Grzelewska-Rzymowska I., Kroczynska-Bednarek J., and Zarkovic J. Comparison of the efficacy and safety of high doses of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate to severe asthma. Respir Med 97 Suppl. B (2003) S21-S26
76. Bousquet J., Meziane H., Chanez P., Mueser M., and Umile A. The response of two different dosages of beclometasone dipropionate suspension for nebulization versus a standard dose of beclometasone dipropionate via a metered-dose inhaler on bronchoprovocation testing in adults with asthma. Respir Med 97 Suppl. B (2003) S11-S14
77. Terzano C., Ricci A., Burinschi V., Nekam K., and Lahovsky J. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma. Respir Med 97 Suppl. B (2003) S35-S40
78. Delacourt C., Dutau G., Lefrançois G., and Clerson P. Beclospin Clinical Development Group. Comparison of the efficacy and safety of nebulized beclometasone dipropionate and budesonide in severe persistent childhood asthma. Respir Med 97 Suppl. B (2003) S27-S33
79. Terzano C., Allegra L., Barkai L., and Cremonesi G. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. Eur Rev Med Pharmacol Sci 5 1 (2001) 17-24
80. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 8 (2007) 775-789
81. Ernst P., Gonzalez A.V., Brassard P., and Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 176 2 (2007) 162-166
82. Ferguson G.T., Calverley P.M.A., Anderson J.A., Willitis L.R., Jenkins C.R., Jones P., et al. Pneumonia reports in the TORCH study. Am J Respir Crit Care Med 177 Abstr Suppl. (2008) A963
83. Brogden R.N., Heel R.C., Speight T.M., and Avery G.S. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 28 2 (1984) 99-126
84. Allen D.B., Mullen M., and Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 93 6 (1994) 967-976
85. Freigang B., and Ashford D.R. Adrenal cortical function after long-term beclomethasone aerosol therapy in early childhood. Ann Allergy 64 4 (1990) 342-344
86. Kaur C., Bansal S.K., and Chhabra S.K. Study on serum and urinary cortisol levels of asthmatic patients after treatment with high dose inhaled beclomethasone dipropionate or budesonide. Indian J Chest Dis Allied Sci 47 2 (2005) 89-95
87. Brus R. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. Arch Intern Med 159 16 (1999) 1903-1908
88. Adams N., Lasserson T.J., Cates C.J., and Jones P.W. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database Syst Rev 4 (2007) CD002310
89. Rau J.L. Design principles of liquid nebulization devices currently in use. Respir Care 47 11 (2002) 1257-1275